Bildkälla: Stockfoto

Alzinova: Gets the Go-ahead to Initiate Clinical Trials - Redeye

Redeye is encouraged by the news that Alzinova has received approval from the regulatory authorities in Finland to initiate clinical trials with its vaccine candidate, ALZ-101.

Redeye is encouraged by the news that Alzinova has received approval from the regulatory authorities in Finland to initiate clinical trials with its vaccine candidate, ALZ-101.
Börsvärldens nyhetsbrev
ANNONSER